- Home
- AMBP vs OGN Comparison
AMBP vs OGN Comparison
Compare AMBP & OGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMBP
- OGN
- Stock Information
- Founded
- AMBP 2021
- OGN 1923
- Country
- AMBP Luxembourg
- OGN United States
- Employees
- AMBP N/A
- OGN N/A
- Industry
- AMBP Containers/Packaging
- OGN Biotechnology: Pharmaceutical Preparations
- Sector
- AMBP Industrials
- OGN Health Care
- Exchange
- AMBP Nasdaq
- OGN Nasdaq
- Market Cap
- AMBP 2.4B
- OGN 2.7B
- IPO Year
- AMBP N/A
- OGN N/A
- Fundamental
- Price
- AMBP $3.33
- OGN $6.75
- Analyst Decision
- AMBP Hold
- OGN Buy
- Analyst Count
- AMBP 6
- OGN 3
- Target Price
- AMBP $4.22
- OGN $17.33
- AVG Volume (30 Days)
- AMBP 1.4M
- OGN 7.3M
- Earning Date
- AMBP 10-23-2025
- OGN 11-10-2025
- Dividend Yield
- AMBP 12.05%
- OGN 1.19%
- EPS Growth
- AMBP N/A
- OGN N/A
- EPS
- AMBP N/A
- OGN 2.69
- Revenue
- AMBP $5,346,000,000.00
- OGN $6,281,000,000.00
- Revenue This Year
- AMBP $11.61
- OGN N/A
- Revenue Next Year
- AMBP $2.17
- OGN $0.65
- P/E Ratio
- AMBP N/A
- OGN $2.50
- Revenue Growth
- AMBP 10.34
- OGN N/A
- 52 Week Low
- AMBP $2.50
- OGN $6.18
- 52 Week High
- AMBP $4.78
- OGN $17.23
- Technical
- Relative Strength Index (RSI)
- AMBP 34.16
- OGN 27.43
- Support Level
- AMBP $3.32
- OGN $6.18
- Resistance Level
- AMBP $3.46
- OGN $6.93
- Average True Range (ATR)
- AMBP 0.14
- OGN 0.37
- MACD
- AMBP -0.05
- OGN -0.15
- Stochastic Oscillator
- AMBP 0.54
- OGN 15.45
About AMBP Ardagh Metal Packaging S.A.
Ardagh Metal Packaging SA is a supplier of infinitely recyclable, sustainable, metal beverage cans and ends to brand owners. The company deals with multiple categories of products including beer, carbonated soft drinks, energy drinks, hard seltzers, juices, pre-mixed cocktails, teas, sparkling waters, and wine. Its segment includes Europe and the Americas. It derives a majority of its revenue from the Americas.
About OGN Organon & Co.
Organon & Co is a science-based pharmaceutical company that develops and delivers health solutions through a portfolio of prescription therapies within women's health, biosimilars, and established brands. The Company's operations include the following product portfolio: Women's health, Biosimilars and Established medicines. Geographically, it derives a majority of its revenue from Europe and Canada followed by the United States and then Asia Pacific and Japan. The company generates the majority of its revenue from the Established Brands product portfolio.